ASA Business Summary

A-SPINE Asia Co., Ltd. (6758.TWO), a subsidiary of United Orthopedic Corporation, operates as a specialized medical device manufacturer focused on the research, development, and global distribution of spinal fixation systems and instruments. The company generates revenue through a three-pronged business model: the sale of proprietary spinal implants (including cervical, thoracic, and lumbar fixation systems), agency fees from the distribution of imported orthopedic devices, and high-margin ODM/OEM manufacturing services for international partners. Its product portfolio is anchored by interbody fusion cages (ACDF, PLIF/TLIF) and vertebral body replacement solutions, catering to the growing demand for minimally invasive spine surgeries. Within the Taiwanese market, A-SPINE Asia competes directly with global giants such as Medtronic and DePuy Synthes, as well as local peers like Wiltrom Co., Ltd. and its own parent, United Orthopedic; it distinguishes itself through vertically integrated manufacturing and a robust regulatory footprint across the Asia-Pacific and European regions. Founded in 2001 by Chih Yi Lin, the company is currently led by CEO Hao Juan Xue and Chairman Dr. Por Lai, who assumed leadership following a pivotal management buyout in 2011. The executive team possesses deep clinical and technical pedigree, with Dr. Lai previously serving as a key figure in the company’s transition toward advanced spinal technology commercialization. The board of directors is characterized by strong institutional and insider backing, with major equity positions held by Chi-Yi Investment Co., Ltd. and Horizon Securities. As of 2026, the leadership continues to focus on expanding the company's footprint in the vertebral compression fracture (VCF) market and leveraging its ISO-certified GMP facilities in New Taipei City to secure further FDA and CE clearances for its next-generation SmartLoc and Vessel-X product lines.